GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Other Current Assets

Nortem Biogroup (XPAR:MLBIO) Other Current Assets : €-0.00 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Other Current Assets?

Nortem Biogroup's other current assets for the quarter that ended in Dec. 2022 was €-0.00 Mil.

Nortem Biogroup's quarterly other current assets increased from . 20 (€0.00 Mil) to Dec. 2021 (€-0.00 Mil) but then declined from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€-0.00Mil).

Nortem Biogroup's annual other current assets increased from . 20 (€0.00 Mil) to Dec. 2021 (€-0.00 Mil) declined from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€-0.00 Mil).


Nortem Biogroup Other Current Assets Historical Data

The historical data trend for Nortem Biogroup's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Other Current Assets Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Other Current Assets
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Other Current Assets - -

Nortem Biogroup Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Nortem Biogroup Other Current Assets Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines